Adult diffuse hepatic hemangiomatosis: A case report and review of the literature - 27/02/22

| pages | 10 |
| Iconographies | 6 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | DHH can be suspected by CT or MRI. Definite diagnosis relies on histological examination. |
• | Progression occurs in some patients. Liver failure is the main causes of death. |
• | DHH can be classified into two types based on the tumor distribution and treatments. |
• | Liver transplantation should be considered for patients with liver failure or congestive heart failure due to DHH. |
Summary |
Diffuse hepatic hemangiomatosis (DHH) is an extremely rare disease, especially in adults. We present a case of DHH involving the entire liver in a 62-year-old male with a giant hemangioma next to the superior mesenteric vein. Based on what we could find in PubMed with pathological evidence, there are only seventeen cases of adult DHH reported in the literature. The female-to-male ratio is 2.4:1. Most patients consult for abdominal pain or distension. Radiographic examination shows multiple diffuse liver nodules. On MRI, these lesions show hypointense T1 and hyperintense T2. Some lesions may show peripheral rim enhancement in the arterial phase but no portovenous washout. In total, 47% of patients with DHH have one or more giant hemangioma(s). Pathology shows that the lesions are lined with flat endothelial cells without cellular atypia, which are stained positive for vascular endothelial markers. Liver failure is the main cause of death. Some patients can be improved by partial hepatectomy. However, there is no effective treatment for most patients. Liver transplantation should be considered in patients with liver failure or congestive heart failure caused by DHH. We attempt to classify DHH into two types based on the distribution of DHH and their treatment.
Le texte complet de cet article est disponible en PDF.Keywords : Diffuse hepatic hemangiomatosis, Diffuse liver cavernous hemangioma, Adult, Imaging, Treatment, Review
Abbreviations : DHH, GCH, MRI, KMS, DIC, AST, ALT, GGT, ALP, Anti-VEGF
Plan
| Author's contributions: Shihua He, Wenjing Chen, Ying Yang, Xiaoli Tang, Guangde Zhou, Jianhui Zhou and Chuanghong Wu: manuscript preparation, comments and review. All authors approved the manuscript. |
Vol 46 - N° 2
Article 101789- février 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?
